Sandu Pharmaceuticals Share Price
01 Oct, 2026 4:01 PM (IST)
Sandu Pharmaceuticals Performance
- Today's Low
- ₹35
- Today's High
- ₹37
- 52 Week Low
- ₹30
- 52 Week High
- ₹50
- Open Price₹37
- Previous Close₹36
- Volume619
- 50 DMA₹37.90
- 100 DMA₹38.60
- 200 DMA₹39.80
Sandu Pharmaceuticals Chart
Investment Returns
- Over 1 Month -3.23%
- Over 3 Month -10.93%
- Over 6 Month + 19.66%
- Over 1 Year -21.7%
Smart Investing Starts Here Start SIP with Sandu Pharmaceuticals for Steady Growth!
Sandu Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.5
- PEG Ratio
- 0.3
- Market Cap Cr
- 35
- P/B Ratio
- 0.8
- Average True Range
- 1.6
- EPS
- 2.5
- Dividend Yield
- 2.7
- MACD Signal
- -0.5
- RSI
- 43.54
- MFI
- 34.01
Latest Stock News Updates
Intimation to the holders of Physical Securities to furnish PAN and KYC details
- BSE India
- 1 day 13 hours ago
Intimation about closure of trading window for Quarter ended 30th September 2026
- BSE India
- 1 week 2 days ago
1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director
- BSE India
- 2 weeks 5 days ago
Sandu Pharmaceuticals Financials
Sandu Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹37.10
- 50 Day
- ₹37.90
- 100 Day
- ₹38.60
- 200 Day
- ₹39.80
Resistance and Support
- R3 38.60
- R2 37.70
- R1 37.10
- S1 35.60
- S2 34.70
- S3 34.10
Sandu Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-11 | Quarterly Results | |
| 2026-07-11 | Others | Inter-alia, to consider 1. To place on record the demise of Shri Umesh B. Sandu Managing Director of the Company. 2. Approve the reconstitution of the Committees of the Board. 3.Other business matters |
| 2026-05-05 | Audited Results & Final Dividend | |
| 2026-02-06 | Quarterly Results | |
| 2025-11-12 | Quarterly Results |
About Sandu Pharmaceuticals
Sandu Pharmaceuticals is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines. View More- NSE Symbol
- SANDUPHQ
- BSE Symbol
- 524703
- ISIN
- INE751D01014
Similar Stocks to Sandu Pharmaceuticals
Popular Stocks
Sandu Pharmaceuticals FAQs
Sandu Pharmaceuticals share price is ₹36 As on 02 October, 2026 | 01:11
The Market Cap of Sandu Pharmaceuticals is ₹35.3 Cr As on 02 October, 2026 | 01:11
The P/E ratio of Sandu Pharmaceuticals is 14.5 As on 02 October, 2026 | 01:11
The PB ratio of Sandu Pharmaceuticals is 0.8 As on 02 October, 2026 | 01:11
The 52 week High & Low of Sandu Pharmaceuticals is ₹50/₹30 respectively As on 02 October, 2026 | 01:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.